- Review of the procedures, frequency, scope and process of the sponsor / CRO used to monitor progress
- Reviewing SOPs and Monitoring Plans, interview personnel, and read trip reports
- Review of items to determine that the clinical study / investigation was conducted in accordance with the signed protocol that was submitted to the FDA
- An assessment of protocol deviations or violations from the approved protocol or FDA regulations and how the sponsor / CRO handled them
- An Assessment of training records, SAE reporting, drug accountability,
- Particular attention to both non-compliant sites and the highest enrollers
- Inconsistencies such as protocol deviations, source documents not mirroring CRFs, unclear informed consents, confused Pis
- Is the PI in compliance with the FDA Form 1572
- Making sure the IC process was clear sans coercion
- Do all subjects meet all Inclusion / exclusion criteriaIs the data reasonable and fits the sourse data
- Are all IRB/IEC approvals reasonable / appropriate
to Know more attend the training
GCP violations and Site Mistakes commonly found During a FDA Investigator Site Inspection/Audit
No comments:
Post a Comment